Latent Microsporidial Infection in Immunocompetent Individuals – A Longitudinal Study by Sak, Bohumil et al.
Latent Microsporidial Infection in Immunocompetent
Individuals – A Longitudinal Study
Bohumil Sak
1, Martin Kva ´c ˇ1,2*, Zuzana Kuc ˇerova ´3, Dana Kve ˇton ˇova ´1, Kamila Sakova ´4
1Biology Centre of the Academy of Sciences of the Czech Republic, v.v.i., Institute of Parasitology, C ˇeske ´ Bude ˇjovice, Czech Republic, 2Faculty of Agriculture, University of
South Bohemia in C ˇeske ´ Bude ˇjovice, C ˇeske ´ Bude ˇjovice, Czech Republic, 3Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America, 4
Laboratory of Virology, C ˇeske ´ Bude ˇjovice Hospital, C ˇeske ´ Bude ˇjovice, Czech Republic
Abstract
Background: Microsporidia (Fungi) have been repeatedly identified as the cause of opportunistic infections predominantly
in immunodeficient individuals such as AIDS patients. However, the global epidemiology of human microsporidiosis is
poorly understood and the ability of microsporidia to survive and multiply in immunocompetent hosts remains unsolved.
Aims: To determine the presence of latent microsporidia infections in apparently healthy humans in the Czech Republic, the
authors tested sera, urine and stool originating from fifteen persons within a three month period examined on a weekly
basis.
Methods: Sera, stool and urine samples originating from fifteen HIV-negative people at risk with occupational exposure to
animals, aged 22–56 years, living in the Czech Republic were tested by indirect immunofluorescence assay (IFA) for the
presence of specific anti-microsporidial antibodies, standard Calcofluor M2R staining for the detection of microsporidian
spores in all urine sediments and stool smears and molecular methods for the microsporidial species determination.
Results: Specific anti-microsporidial antibodies were detected in fourteen individuals, asymptomatic Encephalitozoon spp.
infection was found in thirteen and E. bieneusi infection was detected in seven of those examined. While E. hellem 1A and E.
cuniculi II were the major causative agents identified, seven different genotypes of E. bieneusi were recorded.
Conclusions: These findings clearly show that exposure to microsporidia is common and chronic microsporidiosis is not
linked to any clinical manifestation in healthy population. Moreover, our results indicate much higher incidence of
microsporidial infections among an apparently healthy population than previously reported. These results open the
question about the potential risk of reactivation of latent microsporidiosis in cases of immunosupression causing life-
threatening disease.
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Introduction
Microsporidia have emerged as causative agents of opportunis-
tic infections in AIDS patients and other immunodeficient
individuals. Several species of microsporidia can cause disease in
humans. Intestinal microsporidiosis due to Encephalitozoon (Septata)
intestinalis and Enterocytozoon bieneusi are most frequently reported
among immunocompromised people including patients with
acquired immune deficiency syndrome (AIDS) [1,2] and other
immunocompromised patients such as transplant recipients [3–6].
Encephalitozoon cuniculi and E. hellem are less prevalent among
immunodeficient patients [7,8]. Infections with microsporidia in
immunocompetent individuals such as travelers have also been
described [9,10].
Although the most common clinical symptoms related to
encephalitozoonosis among immunodeficient patients are chronic
diarrhea and malabsorption, they can also cause systemic diseases.
While immunocompetent persons often have mild or self-limiting
disease, AIDS patients can experience weight loss and increased
mortality [11].
Since the studies examining the prevalence of microsporidiosis
have been limited to patients who are infected with human
immunodeficiency virus (HIV) or who have AIDS, the global
epidemiology of human microsporidiosis is poorly understood.
Variation of spore shedding intensity of microsporidia was shown
in both human and animals [12–16]. However, to our knowledge
there have been no reports on the spore shedding pattern of
microsporidia in immunocompetent humans. Therefore we aimed
www.plosntds.org 1 May 2011 | Volume 5 | Issue 5 | e1162to study the pattern of microsporidia spore shedding in a cohort of
asymptomatic apparently healthy people.
Materials and Methods
Ethics statement
The study was approved by the Hospital C ˇeske ´ Bude ˇjovice
ethics committee (protocol no. 202/07).
Written informed consent was obtained from every person prior
to examination.
Stool samples
Between September and December 2007, a total of 180
individual stool and 180 urine samples were collected on the
weekly basis for 3 months from fifteen HIV-negative people at risk
of occupational exposure to various animals, such as farm
ruminants, pigs, poultry and rodents. The male to female ratio
was 8 (53%) to 7 (47%) with mean age of 35611 years and range
between 22–56 years. The samples were stored at 4uC in the dark
without any conservation and examined immediately. Every
specimen in the study was supplemented with data on the person’s
clinical symptoms (e.g., indigestion, abdominal pain).
Serological examination
Prior to the study, serum samples were obtained from all
individuals included and the presence of specific anti-microspor-
idial immunoglobulin G was tested by indirect immunofluores-
cence assay (IFA). IFA was performed with purified whole spores
of E. hellem, E. cuniculi or E. intestinalis grown in vitro in VERO E6
cells and semi-purified spores of E. bieneusi at the concentration 10
5
spores/well (spores kindly provided by Dr. G.S. Visvesvara, CDC
Atlanta, GA, USA). Sera were serially diluted (1:8, 1:16, 1:32,
1:64, 1:128 and 1:256) in PBS and compared with negative and
positive control sera. Sera with positive fluorescence at titers
greater than 128 were considered positive.
Microscopic examination
Standard Calcofluor M2R staining [17] was used for the
detection of microsporidian spores in all urine sediments and stool
smears. Stained slides were examined by fluorescence microscopy
using UV light with a wavelength of 490 nm and at a magnification
of 10006. Positive control slides were used for each examination.
Examination by molecular methods
The DNA was isolated from the stool and urine samples using
homogenization by bead disruption using FastPrep–24 Instrument
(MP Biomedicals, CA, USA) and DNA was extracted using
commercially available isolation kit QIAamp DNA Stool Mini Kit
(QIAGEN, Hilden, Germany) according to the manufacturer’s
instructions. Acquired DNA was stored at 220uC.
The nested PCR protocol by Katzwinkel-Wladarsch et al [18]
amplifying the ITS region of Encephalitozoon spp. and Enterocytozoon
bieneusi using microsporidia-specific primers was performed as
described elsewhere [16]. As positive controls the following were
used: DNA obtained from spores of E. intestinalis originally isolated
from AIDS patients [19] and grown in vitro in VERO E6 cells in
the Laboratory of Veterinary and Medical Protistology at the
Institute of Parasitology ASCR, and DNA from spores of E. bieneusi
of genotype D originally isolated from a pig [16]. PCR products
were visualized on a 2% agarose gel containing 0.2 mg/ml
ethidium bromide and directly sequenced on the ABI3730XL
sequence analyzer (Applied Biosystems, Foster City, CA).
Sequences were aligned and completed using programs Chroma-
sPro (Technelysium, Pty, Ltd.) BioEdit and Clustal X 2.0.6 and
compared with sequences in GenBank.
Results
Specific anti-microsporidial antibodies were detected in four-
teen out of fifteen tested people; 87% of sera reacted with E.
cuniculi, 47% with E. hellem, 13% with E. bieneusi and none with E.
intestinalis (Table 1). None of the individuals demonstrated any
clinical symptoms (loose stool, indigestion, etc.).
While no positive finding was revealed among samples of urine
using microscopy, four stool samples originating from 3 persons
were positive for microsporidia spores, which were subsequently
molecularly characterized as E. bieneusi.
During the twelve week long observation of spore excretion,
microsporidia were molecularly detected in 34 urine samples
(19%) and 39 stool samples (22%) originating from all fifteen tested
people. Each of the person excreted microsporidial spores
intermittently in irregular intervals (Figure 1). The concurrent
infection with two species of Encephalitozoon, E. cuniculi and E. hellem,
and Enterocytozoon bieneusi was detected in 7 individuals, co-infection
with E. cuniculi and E. hellem in three cases and monoinfections with
E. bieneusi, E. hellem or E. cuniculi in one or three individuals,
respectively. No E. intestinalis infection was detected. Whereas both
Encephalitozoon spp. infections were more often found in urine, E.
bieneusi was detected equally in urine and stool samples (Figure 1).
While E. hellem or E. cuniculi infection were caused mainly by
predominant genotype 1A or II, seven different genotypes of E.
bieneusi including novel genotypes CZ4–CZ6 were identified in
both urine and stool samples. All other ITS sequences from the
study samples were a 100% match to the reference genotypes from
GenBank listed in Table 2.
Discussion
The actual extent of microsporidian infections is unknown. Micro-
sporidia were, and still are, often overlooked and misdiagnosed
Author Summary
Microsporidia are a group of obligate intracellular parasitic
fungi that have risen over the past two decades from
obscure organisms to well recognized human pathogens.
Out of 14 species reported to infect humans and causing
more severe symptoms in immunocompromised individ-
uals, microsporidia of the species Encephalitozoon and
Enterocytozoon bieneusi are the most frequent causes of
life-threatening chronic diarrhea and systemic disease in
HIV patients and acute, self-limited diarrhea in immuno-
competent persons. Although the diagnosis and clinical
management of microsporidiosis cases have improved
significantly recently, the epidemiology of human micro-
sporidiosis is still unclear. To identify the occurrence of
latent microsporidia infections in apparently healthy
people, the authors tested sera, urine and stool originating
from fifteen persons within a three month period. They
found specific antibodies against microsporidia in sera
originating from fourteen individuals, and using molecular
tools, they detected microsporidial infection intermittently
in all tested people. The presence of detectable amounts
of microsporidial spores demonstrated that exposure to
microsporidia is more common than previously believed
and microsporidiosis is not linked to any clinical manifes-
tations in healthy people. This finding should make the
clinician more aware of the risk of this unapparent
infection, its potential reactivation after immunosupres-
sion and consequences leading to life-threatening disease.
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E. hellem E. intestinalis E. cuniculi Enterocytozoon bieneusi
1 1:64 1:64 1:128 1:64
2 1:128 1:32 1:128 1:64
3 1:64 1:64 1:128 1:64
4 1:64 1:32 1:128 1:64
5 1:128 1:16 1:128 1:64
6 1:32 1:16 1:128 1:32
7 1:128 1:32 1:128 1:32
8 1:128 1:64 1:128 1:32
9 1:128 1:64 1:128 1:64
10 1:32 1:16 1:32 1:128
11 1:32 1:16 1:128 1:32
12 1:128 1:16 1:128 1:128
13 1:32 1:32 1:128 1:32
14 1:64 1:16 1:64 1:32
15 1:128 1:32 1:128 1:64
Negative serum 1 1:8 1:16 1:32 1:8
Negative serum 2 1:16 1:16 1:16 1:32
Negative serum 3 1:8 1:32 1:32 1:16
Positive serum 1 1:256 1:32 1:16 1:32
Positive serum 2 1:32 1:128 1:64 1:32
Positive serum 3 1:32 1:128 1:256 1:32
Positive serum 4 1:8 1:32 1:32 1:128
doi:10.1371/journal.pntd.0001162.t001
Figure 1. Frequency of microsporidia excretion by naturally infected immunocompetent humans. A urine sediments; B stool samples.
doi:10.1371/journal.pntd.0001162.g001
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they are rather small, and their staining with hematoxylin and eosin
is not sufficient. Most of what is now known about human
microsporidiosis can be attributed to the experience with patients
infected with HIV [1,2]. However, with increased awareness and
improved diagnostics, microsporidia have become more frequently
reported also in immunocompetent individuals, producing asymp-
tomatic infections [20–22]. Despite limited sample number our
findings showed a well-supported correlation between spore presence
in excretions and seropositivity, which discriminates the actual latent
microsporidiosis from simple consumption and passage of spores
through the intestinal tract.
Intermittent spore shedding for a long period has been
experimentally demonstrated for several hosts including rabbits
with E. cuniculi [12], wild-type mice with E. intestinalis [13], pigs
with E. bieneusi [15], budgerigars with naturally acquired
Encephalitozoon spp. infection [23] and HIV-positive patients with
E. bieneusi [14]. The persistence of microsporidia despite resolution
of the intestinal disorder suggests that microsporidia infection may
cause clinical symptoms (e.g., diarrhea) during the early stages of
infection that could be overlooked and resolved even though the
microsporidia persist.
Our survey was performed on a limited sample size from a
highly selected population, which could result in decreased
statistical power. On the basis of present results it is obvious, that
prevalence data of microsporidial infection reported by various
authors reaching up to 38% the case of Encephalitozoon spp. and
51% for E. bieneusi, could be hampered by collection of only a
single sample for diagnosis, especially in low level infections. While
the twelve week sampling enabled us to detect E. cuniculi in 86% of
tested people, E. hellem in 66% and E. bieneusi in 47%, the
hypothetical individual single sampling performed at any day
would identify E. cuniculi in only 0–27% of persons, E. hellem in 0–
13%, and E. bieneusi in 0–13%.
Based on data in the literature and our experience, it seems
that the incidence of microsporidial infections is much higher
than previously reported and microsporidia may represent
neglected etiological agent of more common diseases. However,
it is not known how extensive such silent infections are in
asymptomatic carriers, including both humans and animals,
which have been reported increasingly to harbour various species
and genotypes of microsporidia [16,24,25]. Moreover, the fact
that microsporidia DNA were detected in urine sediments
suggests, that microsporidia are able to disseminate also in
immunocompetent hosts despite previously reported protective
T-cell mediated adaptive immunity together with several
components of innate immunity [26,27]. Furthermore, the
majority of prevalence studies currently rely on detection of
spores in stool samples only. The results of this study clearly
showed that infected seropositive person could excrete detectable
amount of microsporidial DNA via urine, nevertheless examina-
tion of stool sample will be negative. Detection of specific
antibodies seems to be more sensitive than one-shot detection of
spores and can provide more accurate information about ongoing
microsporidia infection.
In conclusion, studies focusing on the epidemiology of
microsporidiosis will more clearly define the environmental
sources of microsporidia that pose a risk for transmission so that
preventative strategies can be implemented. Since no data exist
about latent infection in immunocompetent carriers, possible
infection reactivation in these individuals and person to person
transmission risk via organ donation, such epidemiological data
must be compared with experiments that could solve this question
definitively. Moreover, using detection methods with a high
sensitivity, such as PCR, and consecutive sampling from every
individual is recommended to provide more precise epidemiolog-
ical data.
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Table 2. Detection of microsporidia in urine and stool samples of naturally infected immunocompetent humans.
Species genotype
Number of positive
person Number of positive specimens Reference sequence
urine stool
E. hellem 1 2 0 AY171241
1A 10 10 9 AF338367
E. cuniculi I 1 1 0 AF338410
II 13 16 25 GQ422153
E. bieneusi BfRmr2 1 1 1 EU849132
H 1 1 1 AF135835
EpbC 1 0 1 AF076042
H/F 1 1 1 EU849130
CZ4 1 2 0 HM143725
CZ5 1 0 1 HM143726
CZ6 1 0 1 HM143727
doi:10.1371/journal.pntd.0001162.t002
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